Which hedge funds own ACAD? ACADIA PHARMACEUTICALS INC, Q2 2026 13F holders
50 tracked hedge funds disclosed a position in ACAD (ACADIA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $1.9bn in total. The largest holder by portfolio weight is Palo Alto Investors LP at 10.0% of its book. 10 opened a new position this quarter: Arrowpoint Investment Partners (Singapore) Pte. Ltd., Morgan Creek Capital Management, LLC, Campbell & CO Investment Adviser LLC, Orbimed Advisors LLC. 8 exited: Sofinnova Investments, Inc., Fox Run Management, L.L.C., Avidity Partners Management LP.
- 50
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 10
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 8
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $23.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $20.3m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.9bn
- Combined value Sum of the holders' reported positions in the security.
- 4.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Sofinnova Investments, Inc. | 0.09% | $1.7m |
| Fox Run Management, L.L.C. | 0.08% | $457k |
| Avidity Partners Management LP | 0.06% | $289k |
| Woodline Partners LP | 0.06% | $15.1m |
| Entropy Technologies, LP | 0.02% | $536k |
| Engineers Gate Manager LP | 0.02% | $1.5m |
| Y-Intercept (Hong Kong) Ltd | 0.01% | $571k |
| Brevan Howard Capital Management LP | 0.0% | $204k |
Ownership over time
Who discovered ACAD first? Beta
The run: Q3 2012 → Q2 2015, ×17
| RA Capital Management, L.P. high conviction | Q4 2012 | 5.7% | +55.4 pts |
| Great Point Partners LLC high conviction | Q2 2018 | – | +7.3 pts |
| Palo Alto Investors LP high conviction | Q4 2020 | – | +3.3 pts |
| Opaleye Management Inc. | Q1 2019 | – | +1.6 pts |
| Mark Asset Management LP | Q3 2014 | – | +0.3 pts |
| Sphera Funds Management Ltd. | Q1 2016 | – | +0.1 pts |
| Sivik Global Healthcare LLC | Q3 2015 | – | 0.0 pts |
| Avoro Capital Advisors LLC high conviction | Q2 2015 | – | −2.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.